Extended Use of Long-Acting Reversible Contraception

Publication Date: June 15, 2022
Last Updated: July 25, 2022

Summary of Recommendations

Patients should be counseled that the contraceptive effectiveness of the levonorgestrel 52 mg IUD is maintained beyond the current FDA-approved duration of 7 to 8 years. (1, B)
1317240

Overview

Title

Extended Use of Long-Acting Reversible Contraception

Authoring Organization